DD vs NXL · P/E 127, rev $3.50B vs rev $301.6K
Dupont De Nemours Inc (DD) versus Nexalin Technology Inc. (NXL) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Latest reported DD revenue for 2026-06-30 was $3.50B. Net income was $304.0M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. NXL currently screens at market cap $8.5M.
Not investment advice. Open the DD and NXL stock pages for the full models.
Not investment advice.